Abstract
In this study, the biological potential of a nickel chlorophyll derivative (Ni-PH-A) as a multimodal agent for tumor imaging and photodynamic therapy (PDT) was investigated. Optimum conditions of labeling with 131I were investigated and determined as pH 10 and 1 mg amount of iodogen. Biodistribution results of 131I labeled Ni-PH-A in female rats indicated that radiolabeled Ni-PH-A maximum uptake in the liver, spleen and ovary was observed at 30 min. Intercellular uptake and PDT efficacy of Ni-PH-A were better in MDAH-2774 (human ovarian endometrioid adenocarcinoma) than in MCF-7 (human breast adenocarcinoma) cells. Ni-PH-A might be a promising multimodal agent for lung, ovary and liver tumor imaging and PDT.
Similar content being viewed by others
References
Detty MR, Gibson SL, Wagner S (2004) Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Nucl Med Chem 47(16):3897–3915
Wilson BC (1998) Light sources for photodynamic therapy. Photodyn Ther News 1:6–8
Calin MA, Parascaa SV (2006) Photodynamic therapy in oncology. J Optoelectron Adv M 8:1173–1179
Cai W, Chen K, Mohamedali K (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47(12):2048–2056
Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, Hammer-Wilson MJ, Liaw LHL, Osann K, DiSaia PJ (2002) Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model. Gynecol Oncol 87:64–70
Ludicke F, Gabrecht T, Lange N, Wagnieres G, Van Den Bergh H, Berclaz L, Major AL (2003) Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study. Br J Cancer 88:1780–1784
Loning M, Diddens H, Kupker W, Diedrich K, Huttmann G (2004) Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer 100:1650–1656
Zhong W, Celli JP, Rizvi I, Mai Z, Spring BQ, Yun SH, Hasan T (2009) In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer 101:2015–2022
Whitacre CM, Feyes DK, Satoh T, Grossmann J, Mulvihill JW, Mukhtar H, Oleinick NL (2000) Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res 6(5):2021–2027
Shishkova N, Kuznetsova O, Berezov T (2013) Photodynamic therapy in gastroenterology. J Gastrointest Cancer 44(3):251–259
Choi B-H, Ryoo I-G, Kang HC, Kwak M-K (2014) The sensitivity of cancer cells to pheophorbide a-based photodynamic therapy is enhanced by NRF2 silencing. PLoS One 9(9):e107158
Wang L-W, Huang Z, Lin H, Li Z-S, Hetzel F, Liu B (2013) Effect of photofrin-mediated photo cytotoxicity on a panel of human pancreatic cancer cells. Photodiagn Photodyn Ther 10:244–251
Moeno S, Krause RW, Ermilov EA, Kuzyniak W, Höpfner M (2014) Synthesis and characterization of novel zincphthalocyanines as potential photosensitizersfor photodynamic therapy of cancers. Photochem Photobiol 13:963–970
Zhou M, Ni Q-W, Yang S-Y, Qu C-Y, Zhao P-C, Zhang J-C, Xu L-M (2013) Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell. World J Gastroenterol 19(39):6559–6567
Smith KM, Goff DA, Simpson DJ (1985) The meso substitution of chlorophyll derivatives: direct route for transformation of bacteriopheophorbides d into bacteriopheophorbides. J Am Chem Soc 107(17):4946–4954
Pandit A, Ocakoglu K, Buda F, van Marle T, Holzwarth AR, de Groot HJM (2013) J Phys Chem B 117(38):11292–11298
Ocakoglu K, Er Ö, Lambrecht FY, Yılmaz Süslüer S, Kayabasi C, Gündüz C, Yılmaz O (2015) Evaluation of cancer imaging potential and photodynamic therapy efficacy of copper (II) benzyloxypheophorbide-a. J Drug Target 23(1):89–95
Pandey SK, Gryshuk AL, Sajjad M, Zheng X, Chen Y, Abouzeid MM, Morgan J, Charamisinau I, Nabi HA, Oseroff A, Pandey RK (2005) Multimodality agents for tumor imaging (PET, Fluorescence) and photodynamic therapy. A possible, “see and treat” approach. J Nucl Med Chem 48:6286–6295
Yurt Lambrecht F, Durkan K, Yıldırım Y, Acar Ç (2006) Labeling of acetaminophen with I-131 and biodistribution in rats. Chem Pharm Bull 54(2):245–247
Bayrak E, Yurt Lambrecht F, Durkan K, Yilmaz O (2010) In vitro evaluation, biodistribution in rats of radiolabeled raloxifene. Appl Radiat Isot 68:33–36
Ozgur A, Yurt Lambrecht F, Ocakoglu K, GunduzC Yucebas M (2012) Synthesis and biological evaluation of radiolabeled photosensitizer linked bovine serum albumin nanoparticles as a tumor imaging agent. Int J Pharm 422:472–478
Ashrafi SA, Hosseinimehr SJ, Varmira K, Abedi SM (2012) Radioimmunotherapy with 131I-Bevacizumab as a specific molecule for cells with overexpression of the vascular endothelial growth factor. Biother Radiopharm 27(7):420–425
Chen K, Preuß A, Hackbarth S, Wacker M, Langer K, Röder B (2009) Novel photosensitizer-protein nanoparticles for photodynamic therapy: photophysical characterization and in vitro investigations. Photochem Photobiol B 96:66–74
Ocakoglu K, Bayrak E, Onursal M, Yilmaz O, Lambrecht FY, Holzwarth AR (2011) Evaluation of 99mTc-pheophorbide-a use in infection imaging: a rat model. Appl Radiat Isot 69:1165–1168
Babar AK, Singh AK, Goel HC, Chauhan UPS, Sharma RK (2000) Evaluation of 99mTc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy. Nucl Med Biol 27:419–426
Yang SG, Chang JE, Shin B, Park S, Na K, Shim CK (2010) 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging. J Mater Chem 20:9042–9046
Yilmaz O, Yurt Lambrecht F, Gokmen N, Erbayraktar S, Durkan K (2007) Distribution of 131I-labeled recombinant human erythropoietin in maternal and fetal organs following intravenous administration in pregnant rats. J Radioanal Nucl Chem 273(2):311–313
Ocakoglu K, Yildirim Y, Yurt Lambrecht F, Ocal J, Icli S (2008) Biological investigation of 131I-labeled new water soluble Ru(II) polypyridyl complex. J Appl Radiat Isot 66:115–121
Seyitoglu B, Yurt Lambrecht F, Durkan K (2009) Labeling of Apigenin with 131I and bioactivity of 131I-apigenin in male and female rats. J Radioanal Nucl Chem 279(3):867–873
Pandey SK, Sajjad M, Chen Y, Pandey A, Missert JR, Batt C, Yao R, Nabi HA, Oseroff AR, Pandey RK (2009) Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced pdt efficacy and tumor imaging (124I-PET) ability. Bioconjug Chem 20:274–282
Josefhen LB, Boyle RW (2008) Photodynamic therapy and the development of metal-based photosensitisers. Met Based Drugs. doi:10.1155/2008/276109 Hindawi Publishing Corporation, article, ID 276109S
Carcenac M, Larroque C, Langlois R, van Lier JE, Artus J-C, Pelegrin A (1999) Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal anti body-phthalocyanine conjugates. Photochem Photobiol 70(6):930–936
Liu ZT, Xiong L, Liu Z-P, Miao X-Y, Lin L-W, Wen Y (2014) In vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancer. Nanoscale Res Lett 9:319
Murugesen S, Shetty SJ, Srivastava TS, Samuel AM, Noronha OP (2002) Preparation and biological evaluation of the new chlorin photosensitizer T3, 4BCPC for detection and treatment of tumors. J Photochem Photobiol, B 68(1):33–38
Aprahamian M, Evrard S, Keller P, Tusuji M, Balboni G, Damgè C, Marescaux J (1993) Distribution of pheophorbide A in normal tissues and in an experimental pancreatic cancer in rats. Anticancer Drug Des 8(2):101–114
Usuda J, Kato H, Okunaka T, Furukawa K, Tsutsui H, Yamada K, Suga Y, Honda H, Nagatsuka Y, Ohira T, Tsuboi M, Hirano T (2006) Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol 1(5):489–493
Manoto SL, Houreld NN, Abrahamse H (2013) Phototoxic effect of photodynamic therapy on lung cancer cells grown as a monolayer and three dimensional multicellular spheroids. Lasers Surg Med 45(3):186–194
Shao J, Dai Y, Zhao W, Xie J, Xue J, Ye J, Jia L (2013) Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells. Cancer Lett 330(1):49–56
Acknowledgments
The authors gratefully acknowledge financial support by The Scientific and Technological Research Council of Turkey, TUBITAK (Grant No.: 112T565) and Department of Scientific Projects at Ege University, Izmir, Turkey (12 NBE008).
Conflict of interest
The authors declared no declaration of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Er, O., Lambrecht, F.Y., Ocakoglu, K. et al. Primary evaluation of a nickel-chlorophyll derivative as a multimodality agent for tumor imaging and photodynamic therapy. J Radioanal Nucl Chem 306, 155–163 (2015). https://doi.org/10.1007/s10967-015-4081-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4081-x